FDA Approved: DAPTOMYCIN — Supplemental Application (BE Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for DAPTOMYCIN filed by BE Pharmaceuticals Inc. The approval relates to an ANDA and updates the regulatory status of the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Infective Endocarditis
• Skin and Soft Tissue Infections

Drugs mentioned

• Daptomycin (daptomycin)

Snippet

SUPPL AP for DAPTOMYCIN (DAPTOMYCIN)